Precision Periodontology: Integrating Microbiome, Biomarkers, and Patient-Specific Risk Assessment

Authors

DOI:

https://doi.org/10.68041/medsc.v1i1/06

Keywords:

Periodontitis, Precision Medicine, Risk Assessment, Dysbiosis, Biomarkers, Gingival Crevicular Fluid, Microbiota

Abstract

Periodontitis is a prevalent, polyetiological inflammatory disease in which subgingival dysbiotic communities interact with a vulnerable host. The current stage and grade classification only reflects severity and progression risk, but not the differences in responses to the same treatment for patients with similar presentations. According to this perspective, precision periodontology would require three complementary layers of data, including microbiome profiling, patient-specific risk factors, and host-derived biomarkers. Using an appraisal of the literature based on a personal narrative, it argues that any single layer is an incomplete predictor and that a more convincing pathway to individualized risk stratification, treatment choice, and maintenance planning will be through integrated and longitudinally updated models. This viewpoint suggests a conceptual outline and discusses challenges to implementation: standardization of the assays, validation in a variety of populations, cost, and data governance. Moving from population-average care to individually tailored care will require prospective trials that test biomarker- and microbiome-guided decisions against standard care.

Author Biography

  • Mubashra Inam, Superior University, Lahore , Pakistan

    Department of Allied Health Sciences

References

1. Ravidà A, Travan S, Saleh MH, Greenwell H, Papapanou PN, Sanz M, et al. Agreement among international periodontal experts using the 2017 World Workshop classification of periodontitis. J Periodontol. 2021;92(12):1675-86. https://doi.org/10.1002/JPER.20-0825

2. Kwon T, Lamster IB, Levin L. Current concepts in the management of periodontitis. Int Dent J. 2021;71(6):462-76. https://doi.org/10.1111/idj.12630

3. Abdulkareem AA, Al-Taweel FB, Al-Sharqi AJ, Gul SS, Sha A, Chapple IL. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023;15(1):2197779. https://doi.org/10.1080/20002297.2023.2197779

4. Nearing JT, DeClercq V, Van Limbergen J, Langille MG. Assessing the variation within the oral microbiome of healthy adults. mSphere. 2020;5(5):e00451-20. https://doi.org/10.1128/mSphere.00451-20

5. Hashimoto K, Shimizu D, Ueda S, Miyabe S, Oh-Iwa I, Nagao T, et al. Feasibility of oral microbiome profiles associated with oral squamous cell carcinoma. J Oral Microbiol. 2022;14(1):2105574. https://doi.org/10.1080/20002297.2022.2105574

6. Ahmed E, Azhar F, Akhter M. Host Immune Recognition, Pattern Recognition Receptor Signaling, and Antigen Presentation Pathways Initiating Chronic Host–Pathogen Interactions. J Biomol Pathog Ther. 2026;2(2):102–110. https://doi.org/10.68041/jbpt.v2i2/03

7. Brandt E, Keskin M, Räisänen IT, Tervahartiala T, Mäkitie A, Harmankaya İ, et al. Induction of collagenolytic MMP-8 and -9 tissue destruction cascade in mouth by head and neck cancer radiotherapy: a cohort study. Biomedicines. 2023;12(1):27. https://doi.org/10.3390/biomedicines12010027

8. Asimakopoulou K, Nolan M, McCarthy C, Newton JT. The effect of risk communication on periodontal treatment outcomes: a randomized controlled trial. J Periodontol. 2019;90(9):948-56. https://doi.org/10.1002/JPER.18-0385

9. Li Q, Wu R, Du C, Miao Q. Impact of continuity of care under the model of healthcare integration on treatment outcomes and prognostic recovery of orthodontic patients. Front Med (Lausanne). 2025;12:1632725. https://doi.org/10.3389/fmed.2025.1632725

10. Song J, Zhao H, Pan C, Li C, Liu J, Pan Y. Risk factors of chronic periodontitis on healing response: a multilevel modelling analysis. BMC Med Inform Decis Mak. 2017;17(1):135. https://doi.org/10.1186/s12911-017-0533-2

11. Bostanci N, Manoil D, Van Holm W, Belibasakis GN, Teughels W. Microbial markers for diagnosis and risk assessment for periodontal diseases: A systematic literature search and narrative synthesis. J Clin Periodontol. 2025;52(Suppl 29):125–154. https://doi.org/10.1111/jcpe.14183

12. Saleh MH, Dukka H, Troiano G, Ravidà A, Qazi M, Wang HL, et al. Long term comparison of the prognostic performance of PerioRisk, periodontal risk assessment, periodontal risk calculator, and staging and grading systems. J Periodontol. 2022;93(1):57-68. https://doi.org/10.1002/JPER.20-0662

13. Yuan X, Zhou F, Wang H, Xu X, Xu S, Zhang C, et al. Systemic antibiotics increase microbiota pathogenicity and oral bone loss. Int J Oral Sci. 2023;15(1):4. https://doi.org/10.1038/s41368-022-00212-1

14. Hammami C, Nasri W. Antibiotics in the treatment of periodontitis: a systematic review of the literature. Int J Dent. 2021;2021(1):6846074. https://doi.org/10.1155/2021/6846074

15. Weinert L, El Sayed N, Wensing M, Dannewitz B, Listl S. Exploring barriers to periodontal treatment adherence in patients with periodontitis to inform development of a digital companion: a qualitative study. J Clin Periodontol. 2026;53(1):58-71. https://doi.org/10.1111/jcpe.70044

16. Mills A, Levin L. Inequities in periodontal disease prevalence, prevention, and management. Quintessence Int. 2022;53(2):122. https://doi.org/10.3290/j.qi.b1763677

17. Jönsson B, Abrahamsson KH. Overcoming behavioral obstacles to prevent periodontal disease: behavioral change techniques and self-performed periodontal infection control. Periodontol 2000. 2020;84(1):134-44. https://doi.org/10.1111/prd.12334

Downloads

Published

2026-11-03

Issue

Section

PUBLICATIONS

How to Cite

Precision Periodontology: Integrating Microbiome, Biomarkers, and Patient-Specific Risk Assessment. (2026). MSAR Medical Sciences, 1(1), 23-25. https://doi.org/10.68041/medsc.v1i1/06